Table 2 Antimicrobial susceptibility testing results for the Acinetobacter baumannii
From: First report on bla NDM-1-producing Acinetobacter baumannii in three clinical isolates from Ethiopia
Antimicrobial compound | MIC breakpoint (μg/ml) | Isolate A | Isolate B | Isolate C | ||||
|---|---|---|---|---|---|---|---|---|
μg/ml | mm | μg/ml | mm | μg/ml | mm | |||
S ≤ | R > | A. baumannii | A. baumannii | A. baumannii | ||||
Chloramphenicol | – | – | >256 | n.a. | >256 | n.a. | >256 | n.a. |
Fosfomycin | – | – | >256 | – | >256 | – | >256 | – |
Ciprofloxacin | 1 | 1 | >32 | n.a. | >32 | n.a. | >32 | n.a. |
Erythromycin | – | – | >256 | n.a. | >256 | n.a. | >256 | n.a. |
Amoxicillin | – | – | >256 | n.a. | >256 | n.a. | >256 | n.a. |
Amoxicillin/Clavulanic Acid | – | – | >256 | 12 | >256 | 13 | >256 | 14 |
Cefoxitin | – | – | >256 | n.a. | >256 | n.a. | >256 | n.a. |
Ceftazidime | – | – | >256 | n.a. | >256 | n.a. | >256 | n.a. |
Cefepime | – | – | >256 | n.a. | >256 | n.a. | >256 | n.a. |
Meropenem | 2 | 8 | >32 | n.a. | >32 | 8 [21/15] | >32 | n.a. |
Aztreonam | – | – | >256 | – | >256 | – | >256 | – |
Amikacin | 8 | 16 | 3 | 22 [18/15] | 3.5 | 23 [18/15] | 3.5 | 23 [18/15] |
Gentamicin | 4 | 4 | 32 | n.a. | 32 | n.a. | 32 | n.a. |
Trimethoprim/Sulfamethoxazole | 2 | 4 | 0,25 | 25 [16/13] | 32 | n.a. | 32 | n.a. |
Polymyxin B | 2 | 2 | 1,5 | 13 | 1 | 17 | 1 | 17 |
Tetracycline | – | – | 12 | 18 | 12 | 20 | 12 | 21 |